Total Payments
$108,087
2024 Payments
$153.37
Companies
25
Transactions
187
Medicare Patients
11,194
Medicare Billing
$557,984
Payment Breakdown by Category
Other$96,848 (89.6%)
Food & Beverage$7,205 (6.7%)
Travel$3,819 (3.5%)
Education$214.71 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $96,848 | 45 | 89.6% |
| Food and Beverage | $7,205 | 119 | 6.7% |
| Travel and Lodging | $3,819 | 16 | 3.5% |
| Education | $214.71 | 7 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $47,498 | 57 | $0 (2023) |
| Astellas Pharma US Inc | $29,524 | 25 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $27,648 | 28 | $0 (2024) |
| Boston Scientific Corporation | $671.98 | 8 | $0 (2024) |
| Abbott Laboratories | $440.56 | 9 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $429.46 | 7 | $0 (2019) |
| BIOTRONIK INC. | $275.12 | 2 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $273.73 | 16 | $0 (2021) |
| Edwards Lifesciences Corporation | $176.55 | 2 | $0 (2023) |
| Medtronic Vascular, Inc. | $153.42 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $153.37 | 6 | Boston Scientific Corporation ($35.42) |
| 2023 | $4,051 | 11 | Amgen Inc. ($3,783) |
| 2022 | $10,196 | 13 | Amgen Inc. ($6,294) |
| 2021 | $5,759 | 10 | Amgen Inc. ($4,818) |
| 2020 | $15,839 | 21 | Amgen Inc. ($8,909) |
| 2019 | $15,071 | 41 | Amgen Inc. ($7,507) |
| 2018 | $25,797 | 41 | Amgen Inc. ($11,519) |
| 2017 | $31,220 | 44 | Novartis Pharmaceuticals Corporation ($19,850) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/26/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $31.73 | General |
| Category: Coronary | ||||||
| 08/23/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Not Applicable | ||||||
| 06/15/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $35.42 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/14/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Cardiovascular Diseases | ||||||
| 03/11/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Heart Failure | ||||||
| 02/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/09/2023 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $120.40 | General |
| Category: LUX-Dx_CRM | ||||||
| 11/07/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/13/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $51.55 | General |
| 10/09/2023 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 10/05/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Heart Failure | ||||||
| 10/04/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
| 09/18/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Cardiology | ||||||
| 06/16/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/10/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/29/2023 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $817.25 | General |
| Category: Cardiology | ||||||
| 02/16/2023 | Amgen Inc. | — | Education | In-kind items and services | $17.26 | General |
| 12/13/2022 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 12/06/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $107.95 | General |
| Category: Cardiology | ||||||
| 11/18/2022 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $467.00 | General |
| Category: Cardiology | ||||||
| 10/26/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.65 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/04/2022 | Astellas Pharma US Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,885.00 | General |
| 10/04/2022 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $88.90 | General |
| 08/25/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/26/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.42 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,815 | 3,785 | $1.0M | $134,469 |
| 2022 | 20 | 2,824 | 3,984 | $1.0M | $135,875 |
| 2021 | 18 | 2,785 | 4,144 | $1.1M | $151,480 |
| 2020 | 22 | 2,770 | 4,047 | $603,806 | $136,160 |
Total Patients
11,194
Total Services
15,960
Medicare Billing
$557,984
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 445 | 843 | $276,952 | $61,778 | 22.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 179 | 179 | $81,074 | $17,488 | 21.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 274 | 281 | $157,572 | $14,269 | 9.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 201 | 201 | $309,966 | $11,444 | 3.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 945 | 1,312 | $40,016 | $8,229 | 20.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 220 | 220 | $16,074 | $3,496 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 56 | 64 | $14,206 | $3,210 | 22.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 27 | 28 | $13,604 | $3,020 | 22.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 220 | 220 | $10,716 | $2,333 | 21.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 44 | 80 | $8,430 | $1,668 | 19.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 12 | 53 | $6,420 | $1,517 | 23.6% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Facility | 2023 | 14 | 81 | $7,528 | $1,493 | 19.8% |
| 78803 | Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | Facility | 2023 | 29 | 29 | $36,693 | $1,125 | 3.1% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Facility | 2023 | 14 | 29 | $5,487 | $709.20 | 12.9% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Facility | 2023 | 11 | 23 | $3,722 | $613.65 | 16.5% |
| 93280 | Programming of dual lead pacemaker system | Facility | 2023 | 24 | 24 | $6,448 | $603.25 | 9.4% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Facility | 2023 | 30 | 48 | $9,152 | $584.50 | 6.4% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 22 | 22 | $1,920 | $433.02 | 22.6% |
| 76376 | 3d radiographic procedure | Facility | 2023 | 33 | 33 | $1,056 | $244.80 | 23.2% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 15 | 15 | $2,891 | $210.46 | 7.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 465 | 892 | $290,375 | $64,828 | 22.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 140 | 140 | $62,720 | $14,416 | 23.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 253 | 258 | $170,716 | $13,738 | 8.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 200 | 201 | $306,123 | $11,625 | 3.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 1,061 | 1,517 | $53,298 | $9,620 | 18.0% |
About Dr. Karan Munuswamy, MD
Dr. Karan Munuswamy, MD is a Cardiovascular Disease healthcare provider based in Fort Lauderdale, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447228101.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karan Munuswamy, MD has received a total of $108,087 in payments from pharmaceutical and medical device companies, with $153.37 received in 2024. These payments were reported across 187 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($96,848).
As a Medicare-enrolled provider, Munuswamy has provided services to 11,194 Medicare beneficiaries, totaling 15,960 services with total Medicare billing of $557,984. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Fort Lauderdale, FL
- Active Since 03/09/2006
- Last Updated 03/07/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1447228101
Products in Payments
- Repatha (Biological) $47,463
- ENTRESTO (Drug) $27,604
- Lexiscan (Drug) $5,916
- ONPATTRO (Drug) $429.46
- WATCHMAN (Device) $372.33
- XARELTO (Drug) $273.73
- ELIQUIS (Drug) $159.31
- Vascepa (Drug) $146.36
- Circulatory Support (Device) $136.87
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $125.00
- LUX-Dx Insertable Cardiac Monitor (Device) $120.40
- EMBLEM S-ICD (Device) $118.58
- Claria MRI (Device) $117.33
- HeartMate (Device) $116.96
- REGADENOSON (Drug) $107.00
- LifeVest (Device) $96.79
- Coronary Orbital Atherectomy System (Device) $94.21
- WATCHMAN FLX (Device) $60.67
- PRADAXA (Drug) $53.16
- CRT-Ds (Device) $51.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Fort Lauderdale
David Perloff, Md, MD
Cardiovascular Disease — Payments: $477,330
Cardiovascular Disease $477,330
Joel Gellman, Md, MD
Cardiovascular Disease — Payments: $284,701
Cardiovascular Disease $284,701
Dr. Joshua Larned, M.d, M.D
Cardiovascular Disease — Payments: $41,848
Cardiovascular Disease $41,848
Ronald Pachon, M.d, M.D
Cardiovascular Disease — Payments: $37,567
Cardiovascular Disease $37,567
Joshua Purow, Md, MD
Cardiovascular Disease — Payments: $33,217
Cardiovascular Disease $33,217
Ricardo Vicuna, M.d, M.D
Cardiovascular Disease — Payments: $4,699
Cardiovascular Disease $4,699